Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Corticosteroids Inhalation Formulation Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4659428
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Corticosteroids Inhalation Formulation market size was valued at US$ 20690 million in 2024 and is forecast to a readjusted size of USD 33120 million by 2031 with a CAGR of 7.0% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Corticosteroid inhalation formulations are a cornerstone in the long-term management of asthma and chronic obstructive pulmonary disease (COPD), aiming to control inflammation in the airways. These formulations deliver corticosteroids directly to the lungs, minimizing systemic absorption and reducing the risk of side effects compared to oral steroids. By reducing inflammation, corticosteroids help prevent asthma attacks and improve lung function. Inhalation devices like metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers are commonly used to administer these medications. Advances in inhaler technology have enhanced the precision and efficiency of drug delivery, improving patient adherence and overall disease control. Combination inhalers that pair corticosteroids with bronchodilators are also widely used, providing both anti-inflammatory and bronchodilatory effects in a single formulation.
This report is a detailed and comprehensive analysis for global Corticosteroids Inhalation Formulation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Corticosteroids Inhalation Formulation market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Corticosteroids Inhalation Formulation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Corticosteroids Inhalation Formulation market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Corticosteroids Inhalation Formulation market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Corticosteroids Inhalation Formulation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Corticosteroids Inhalation Formulation market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Corticosteroids Inhalation Formulation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluticasone
Budesonide
Mometasone Furoate
Beclomethasone
Other
Market segment by Application
Hospitals
Specialty Clinics
Retail Pharmacy Chains
Online Pharmacies
Other
Major players covered
Recipharm AB
GSK
AstraZeneca
Novartis
Teva Respiratory
Boehringer Ingelheim International
Cipla
Merck
Lupin
Perrigo
Viatris
Organon Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Corticosteroids Inhalation Formulation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Corticosteroids Inhalation Formulation, with price, sales quantity, revenue, and global market share of Corticosteroids Inhalation Formulation from 2020 to 2025.
Chapter 3, the Corticosteroids Inhalation Formulation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Corticosteroids Inhalation Formulation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Corticosteroids Inhalation Formulation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Corticosteroids Inhalation Formulation.
Chapter 14 and 15, to describe Corticosteroids Inhalation Formulation sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Corticosteroids Inhalation Formulation Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Fluticasone
    • 1.3.3 Budesonide
    • 1.3.4 Mometasone Furoate
    • 1.3.5 Beclomethasone
    • 1.3.6 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Corticosteroids Inhalation Formulation Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Specialty Clinics
    • 1.4.4 Retail Pharmacy Chains
    • 1.4.5 Online Pharmacies
    • 1.4.6 Other
  • 1.5 Global Corticosteroids Inhalation Formulation Market Size & Forecast
    • 1.5.1 Global Corticosteroids Inhalation Formulation Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Corticosteroids Inhalation Formulation Sales Quantity (2020-2031)
    • 1.5.3 Global Corticosteroids Inhalation Formulation Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Recipharm AB
    • 2.1.1 Recipharm AB Details
    • 2.1.2 Recipharm AB Major Business
    • 2.1.3 Recipharm AB Corticosteroids Inhalation Formulation Product and Services
    • 2.1.4 Recipharm AB Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Recipharm AB Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Corticosteroids Inhalation Formulation Product and Services
    • 2.2.4 GSK Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 AstraZeneca
    • 2.3.1 AstraZeneca Details
    • 2.3.2 AstraZeneca Major Business
    • 2.3.3 AstraZeneca Corticosteroids Inhalation Formulation Product and Services
    • 2.3.4 AstraZeneca Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 AstraZeneca Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Corticosteroids Inhalation Formulation Product and Services
    • 2.4.4 Novartis Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Teva Respiratory
    • 2.5.1 Teva Respiratory Details
    • 2.5.2 Teva Respiratory Major Business
    • 2.5.3 Teva Respiratory Corticosteroids Inhalation Formulation Product and Services
    • 2.5.4 Teva Respiratory Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Teva Respiratory Recent Developments/Updates
  • 2.6 Boehringer Ingelheim International
    • 2.6.1 Boehringer Ingelheim International Details
    • 2.6.2 Boehringer Ingelheim International Major Business
    • 2.6.3 Boehringer Ingelheim International Corticosteroids Inhalation Formulation Product and Services
    • 2.6.4 Boehringer Ingelheim International Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Boehringer Ingelheim International Recent Developments/Updates
  • 2.7 Cipla
    • 2.7.1 Cipla Details
    • 2.7.2 Cipla Major Business
    • 2.7.3 Cipla Corticosteroids Inhalation Formulation Product and Services
    • 2.7.4 Cipla Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Cipla Recent Developments/Updates
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Corticosteroids Inhalation Formulation Product and Services
    • 2.8.4 Merck Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Merck Recent Developments/Updates
  • 2.9 Lupin
    • 2.9.1 Lupin Details
    • 2.9.2 Lupin Major Business
    • 2.9.3 Lupin Corticosteroids Inhalation Formulation Product and Services
    • 2.9.4 Lupin Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Lupin Recent Developments/Updates
  • 2.10 Perrigo
    • 2.10.1 Perrigo Details
    • 2.10.2 Perrigo Major Business
    • 2.10.3 Perrigo Corticosteroids Inhalation Formulation Product and Services
    • 2.10.4 Perrigo Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Perrigo Recent Developments/Updates
  • 2.11 Viatris
    • 2.11.1 Viatris Details
    • 2.11.2 Viatris Major Business
    • 2.11.3 Viatris Corticosteroids Inhalation Formulation Product and Services
    • 2.11.4 Viatris Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Viatris Recent Developments/Updates
  • 2.12 Organon Group
    • 2.12.1 Organon Group Details
    • 2.12.2 Organon Group Major Business
    • 2.12.3 Organon Group Corticosteroids Inhalation Formulation Product and Services
    • 2.12.4 Organon Group Corticosteroids Inhalation Formulation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Organon Group Recent Developments/Updates

3 Competitive Environment: Corticosteroids Inhalation Formulation by Manufacturer

  • 3.1 Global Corticosteroids Inhalation Formulation Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Corticosteroids Inhalation Formulation Revenue by Manufacturer (2020-2025)
  • 3.3 Global Corticosteroids Inhalation Formulation Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Corticosteroids Inhalation Formulation by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Corticosteroids Inhalation Formulation Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Corticosteroids Inhalation Formulation Manufacturer Market Share in 2024
  • 3.5 Corticosteroids Inhalation Formulation Market: Overall Company Footprint Analysis
    • 3.5.1 Corticosteroids Inhalation Formulation Market: Region Footprint
    • 3.5.2 Corticosteroids Inhalation Formulation Market: Company Product Type Footprint
    • 3.5.3 Corticosteroids Inhalation Formulation Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Corticosteroids Inhalation Formulation Market Size by Region
    • 4.1.1 Global Corticosteroids Inhalation Formulation Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Corticosteroids Inhalation Formulation Consumption Value by Region (2020-2031)
    • 4.1.3 Global Corticosteroids Inhalation Formulation Average Price by Region (2020-2031)
  • 4.2 North America Corticosteroids Inhalation Formulation Consumption Value (2020-2031)
  • 4.3 Europe Corticosteroids Inhalation Formulation Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Corticosteroids Inhalation Formulation Consumption Value (2020-2031)
  • 4.5 South America Corticosteroids Inhalation Formulation Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Corticosteroids Inhalation Formulation Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 5.2 Global Corticosteroids Inhalation Formulation Consumption Value by Type (2020-2031)
  • 5.3 Global Corticosteroids Inhalation Formulation Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 6.2 Global Corticosteroids Inhalation Formulation Consumption Value by Application (2020-2031)
  • 6.3 Global Corticosteroids Inhalation Formulation Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 7.2 North America Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 7.3 North America Corticosteroids Inhalation Formulation Market Size by Country
    • 7.3.1 North America Corticosteroids Inhalation Formulation Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Corticosteroids Inhalation Formulation Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 8.2 Europe Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 8.3 Europe Corticosteroids Inhalation Formulation Market Size by Country
    • 8.3.1 Europe Corticosteroids Inhalation Formulation Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Corticosteroids Inhalation Formulation Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Corticosteroids Inhalation Formulation Market Size by Region
    • 9.3.1 Asia-Pacific Corticosteroids Inhalation Formulation Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Corticosteroids Inhalation Formulation Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 10.2 South America Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 10.3 South America Corticosteroids Inhalation Formulation Market Size by Country
    • 10.3.1 South America Corticosteroids Inhalation Formulation Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Corticosteroids Inhalation Formulation Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Corticosteroids Inhalation Formulation Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Corticosteroids Inhalation Formulation Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Corticosteroids Inhalation Formulation Market Size by Country
    • 11.3.1 Middle East & Africa Corticosteroids Inhalation Formulation Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Corticosteroids Inhalation Formulation Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Corticosteroids Inhalation Formulation Market Drivers
  • 12.2 Corticosteroids Inhalation Formulation Market Restraints
  • 12.3 Corticosteroids Inhalation Formulation Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Corticosteroids Inhalation Formulation and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Corticosteroids Inhalation Formulation
  • 13.3 Corticosteroids Inhalation Formulation Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Corticosteroids Inhalation Formulation Typical Distributors
  • 14.3 Corticosteroids Inhalation Formulation Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Corticosteroids Inhalation Formulation. Industry analysis & Market Report on Corticosteroids Inhalation Formulation is a syndicated market report, published as Global Corticosteroids Inhalation Formulation Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Corticosteroids Inhalation Formulation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo